SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-17-102730
Filing Date
2017-03-30
Accepted
2017-03-30 07:01:54
Documents
72
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d325199d10k.htm 10-K 641721
2 EX-10.20 d325199dex1020.htm EX-10.20 62618
3 EX-10.21 d325199dex1021.htm EX-10.21 24628
4 EX-23.1 d325199dex231.htm EX-23.1 1578
5 EX-31.1 d325199dex311.htm EX-31.1 9123
6 EX-32.1 d325199dex321.htm EX-32.1 3592
13 GRAPHIC g325199g0323075515741.jpg GRAPHIC 35898
  Complete submission text file 0001193125-17-102730.txt   3971123

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT rxii-20161231.xml EX-101.INS 570463
8 XBRL TAXONOMY EXTENSION SCHEMA rxii-20161231.xsd EX-101.SCH 44832
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rxii-20161231_cal.xml EX-101.CAL 67098
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rxii-20161231_def.xml EX-101.DEF 178663
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE rxii-20161231_lab.xml EX-101.LAB 406872
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rxii-20161231_pre.xml EX-101.PRE 295017
Mailing Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752
Business Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752 (508) 767-3861
RXi Pharmaceuticals Corp (Filer) CIK: 0001533040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36304 | Film No.: 17723735
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences